The health-economic impact of urine albumin-to-creatinine ratio testing for chronic kidney disease in Japanese non-diabetic patients
Clinical and Experimental Nephrology · 2025-05 · 29 (5) · 583-595
DOI: 10.1007/s10157-024-02600-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Nephrology, online erschienen am 16.12.2024. Verfasst von Tsuneo Konta und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Hygiene, Yamagata University Graduate School of Medicine, Yamagata, Japan. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Albuminuria, Creatinine, Health Care Costs. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health, Labour and Welfare, Bayer Yakuhin.
Abstract (Originalsprache)
Background
The objective of this analysis was to estimate the clinical and economic impact of undertaking urine albumin-to-creatinine ratio (UACR) testing alongside regular estimated glomerular filtration rate testing for chronic kidney disease in non-diabetic Japanese patients versus no testing and versus urine protein-creatinine ratio (UPCR) testing.
Methods
An economic model, taking a Japanese healthcare perspective, estimated the health-economic impact of UACR testing over a lifetime time horizon. Outcomes reported were additional costs, clinical benefits measured, such as prevented dialyses and cardiovascular events, quality-adjusted life years gained, and incremental cost-effectiveness ratios. Health states were derived from risk levels reported in the Kidney Disease: Improving Global Outcomes heatmap. Results were derived assuming that after testing, treatment was available in the form of current standard-of-care or emerging chronic kidney disease therapies.
Results
Repeated UACR testing was found to be cost-effective compared to both no urine testing and UPCR testing, with incremental cost-effectiveness ratios of ¥1,953,958 and ¥1,966,433, respectively.
Conclusion
Overall, this model demonstrates the health-economic value of undertaking UACR testing within the non-diabetic Japanese population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health and Hygiene, Yamagata University Graduate School of Medicine, Yamagata, Japan.
- Division of Nephrology and Hypertension, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba, Japan.
- Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
- Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Minato City, Japan.
- Bayer Yakuhin Ltd, Osaka, Japan.
- Bayer Yakuhin Ltd, Osaka, Japan. yoko.shijoh@bayer.com.
Förderung
- Ministry of Health, Labour and Welfare
- Bayer Yakuhin
Zitieren
APA
Konta, T., Asahi, K., Tamura, K., Tanaka, F., Fukui, A., Nakamura, Y., Hirose, J., Ohara, K., Shijoh, Y., Carter, M., Meredith, K., Harris, J., Åkerborg, Ö., Kashihara, N., & Yokoo, T. (2025). The health-economic impact of urine albumin-to-creatinine ratio testing for chronic kidney disease in Japanese non-diabetic patients. Clinical and Experimental Nephrology, 29(5), 583-595. https://doi.org/10.1007/s10157-024-02600-9
Vancouver
Konta T, Asahi K, Tamura K, Tanaka F, Fukui A, Nakamura Y, et al. The health-economic impact of urine albumin-to-creatinine ratio testing for chronic kidney disease in Japanese non-diabetic patients. Clinical and Experimental Nephrology. 2025;29(5):583-595. doi:10.1007/s10157-024-02600-9
BibTeX
@article{Konta2025,
author = {Konta, Tsuneo and Asahi, Koichi and Tamura, Kouichi and Tanaka, Fumitaka and Fukui, Akira and Nakamura, Yusuke and Hirose, Junichi and Ohara, Kenichi and Shijoh, Yoko and Carter, Matthew and Meredith, Kimberley and Harris, James and Åkerborg, Örjan and Kashihara, Naoki and Yokoo, Takashi},
title = {The health-economic impact of urine albumin-to-creatinine ratio testing for chronic kidney disease in Japanese non-diabetic patients},
journal = {Clinical and Experimental Nephrology},
year = {2025},
volume = {29},
number = {5},
pages = {583--595},
doi = {10.1007/s10157-024-02600-9}
}
EUVIMED